- Global Pharma News & Resources

Pemetrexed Market to Grow at CAGR of 1.3% from 2021 to 2027 | In-Depth Research on Market Dynamics, Applications and Emerging Growth Factors


Pemetrexed is used to treat certain types of cancer (such as lung cancer and mesothelioma). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells. Pemetrexed is manufactured and marketed under the brand name Alimta. In 2004, Alimta (Pemetrexed injection) was approved by the Food and Drug Administration (FDA) in combination with cisplatin as an initial treatment for patients with malignant pleural mesothelioma. Alimta is a patented drug of Eli Lilly and Company, it has vitamin regimen patent in the United States and Europe up to 2021 and pediatric exclusivity in the U.S. up to 2022.

Request Here For Market Latest Insights:


Increasing demand for generic versions of pemetrexed or the increasing approval and launch of generic versions of pemetrexed is expected to drive the global pemetrexed market growth during the forecast period. For instance, in October 2017, Eagle Pharmaceuticals, Inc. announced that the company has received final approval from FDA for its novel product, PEMFEXY (pemetrexed for injection), a branded alternative to ALIMTA.

The launch of generic versions of pemetrexed is expected to increase the affordability of the drugs, as generic drugs are cost-effective, driving the global pemetrexed market growth. For instance, in 2018, Stadapharm GmbH launched Pemetrexed STADA, a generic version of Alimta in Europe.

Key Players:

Key players active in the global pemetrexed market are Eagle Pharmaceuticals, Stada Arzneimittel AG, Eli Lilly and Company, and Others.

Purchase this Report at Discount Of US $2000 Flat OFF –

Table of Content

Global Pemetrexed Market Research Report
Section 1: Global Pemetrexed Industry Overview
Section 2: Global Economic Impact on Pemetrexed Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Pemetrexed Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Pemetrexed Market Forecast

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 22-Sep-2021